Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirect Line Regulatory News (DLG)

Share Price Information for Direct Line (DLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 196.80
Bid: 198.00
Ask: 198.50
Change: -4.00 (-1.99%)
Spread: 0.50 (0.253%)
Open: 200.00
High: 205.00
Low: 196.80
Prev. Close: 200.80
DLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Post-stabilisation announcement

25 Sep 2013 12:40

RNS Number : 8650O
UBS Limited
25 September 2013
 



Post-stabilisation announcement

 

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

 

DIRECT LINE INSURANCE GROUP PLC

Stabilisation Notice

 

 

 

UBS Limited (contact: Gareth McCartney ; telephone: 0044 20756 82227), in its capacity as Stabilisation Manager, hereby gives notice that no Stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager named in relation to the offer of the following securities.

 

The Securities:

Vendor:

Royal Bank of Scotland Group plc

Underlying shares:

Direct Line Insurance Group plc

ISIN:

GB00B89W0M42

Base size:

272.7 million shares

Offer price:

210 pence

Maximum size of over-allotment facility:

10% of the aggregate nominal amount stated above

 

In connection with its Stabilisation activities, Royal Bank of Scotland Group plc granted UBS Limited, on behalf of the Underwriters, an over-allotment option, exercisable once for a period of 30 days after the announcement of the Offer Price on 20 September 2013 which, if exercised would require Royal Bank of Scotland Group plc to sell up to 10 per cent. of the aggregate number of Offering Shares available in the Offering (before any exercise of the Over-allotment Option) at the Offer Price to cover short positions arising from such over-allotments (if any) and/or sales of shares effected by it during the Stabilisation period.

 

UBS Limited agreed with Royal Bank of Scotland Group plc that any over-allotment of the Offering Shares by it or any of its agents will be up to a maximum of 10 per cent. of the total number of the Offering Shares (before any exercise of the Over-allotment Option).

 

Number of Offering Shares: 272.7 million

Number of shares subject to the over-allotment option: 27.3 million

 

No stabilisation trades have or will take place.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

The offer of the above securities and the distribution of this announcement and other information in connection with the offer of the above securities in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STANKPDNKBKDOCB
Date   Source Headline
29th Feb 20246:11 pmRNSForm 8.3 -Direct Line Insurance Group plc
29th Feb 20245:58 pmRNSForm 8.3 - Ageas SA NV
29th Feb 20243:30 pmEQSForm 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
29th Feb 20243:28 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 20243:27 pmRNSDirect Line Insurance Group plc
29th Feb 20243:20 pmRNSForm 8.3 - Direct Line Insurance Group Plc
29th Feb 20243:17 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 20243:15 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 20243:00 pmRNSForm 8.3 - Direct Line Insurance Group PLC
29th Feb 20242:45 pmRNSForm 8.3 - Direct Line Insurance Group Plc
29th Feb 20242:45 pmRNSForm 8.3 - Ageas NV
29th Feb 20242:41 pmRNSForm 8.3 - Direct Line Insurance Group PLC
29th Feb 20242:19 pmRNSForm 8.3 - [Ageas SA/NV]
29th Feb 20242:17 pmRNSForm 8.3 - [Direct Line Insurance Group plc]
29th Feb 20241:23 pmGNWMan Group PLC : Form 8.3 - Direct Line Insurance Group plc
29th Feb 202412:53 pmRNSForm 8.3 - Direct Line Insurance Group Plc
29th Feb 202412:43 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 202412:25 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 202412:21 pmRNSForm 8.3 - Direct Line Insurance Group PLC
29th Feb 202412:19 pmRNSForm 8.3 - AGEAS NV
29th Feb 202412:09 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 202412:00 pmRNSDirector/PDMR Shareholding
29th Feb 202411:32 amRNS20240228_DIRECT LINE INSURANCE_8.5 EPT RI_UK_MLI
29th Feb 202411:31 amRNS20240228_DIRECT LINE INSU_8.5 EPT NON-RI_UK_BOFASE
29th Feb 202411:31 amRNSForm 8.5 (EPT/RI) - DIRECTLINE INSURANCE GROUP PL
29th Feb 202411:09 amPRNForm 8 (OPD) - Direct Line Insurance Group Plc
29th Feb 202411:05 amRNSForm 8.5 (EPT/RI)- Direct Line Insurance Group plc
29th Feb 202410:58 amPRNForm 8.3 - Direct Line Insurance Group plc
29th Feb 202410:35 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - Direct Line Insurance Group plc - Ordinary Shares
29th Feb 202410:25 amRNSForm 8.3 - Ageas SA/NV
29th Feb 202410:20 amRNSForm 8.3 - Direct Line Insurance Group PLC
29th Feb 20249:47 amRNSForm 8.5 (EPT/RI)
28th Feb 20243:12 pmRNSResponse to Statement by Ageas SA/NV
28th Feb 20242:30 pmRNSForm 8.3 - Ageas SA/NV
28th Feb 202412:18 pmRNSPossible offer for Direct Line Insurance Group Plc
9th Feb 20248:00 amRNSCEO joining & preliminary results dates
31st Jan 20244:36 pmRNSDirector/PDMR Shareholding
30th Jan 20246:15 pmRNSDirector/PDMR Shareholding
28th Dec 20231:00 pmRNSDirector/PDMR Shareholding
7th Dec 202310:30 amRNSDirectorate Change
5th Dec 20236:09 pmRNSHolding(s) in Company
28th Nov 20234:30 pmRNSDirector/PDMR Shareholding
7th Nov 20237:00 amRNSTrading Update for Q3 2023
30th Oct 20236:00 pmRNSDirector/PDMR Shareholding
19th Oct 20231:45 pmRNSDirectorate Change
19th Oct 202311:32 amRNSResult of General Meeting
3rd Oct 202312:45 pmRNSCircular and Notice of General Meeting
28th Sep 20233:00 pmRNSDirector/PDMR Shareholding
22nd Sep 202311:48 amRNSHolding(s) in Company
22nd Sep 202310:30 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.